Vancouver, British Columbia–(Newsfile Corp. – February 24, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (the “ Acquiror“) announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 22, 2022 and February 23, 2022, it sold a total of 4,500,000 common shares in the capital of Ionic Brands Corp. (the “Issuer” and the common shares of the Issuer…


Previous articlePT296 – Dr. David Luke – Vital Psychedelic Conversations
Next articlePsychedelic Bulletin: Following the Money – How Much do Psychedelics Companies Spend on R&D?